Latest Articles
-
Abbott Laboratories Stock Hands $28 Bil Back – Worth a Look?
In the last five years, Abbott Laboratories (ABT) stock has returned $28 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the mar...
-
Why Is Abbott Stock Trending Lower?
Abbott Laboratories (ABT) has dropped by roughly 26% over the last five months, with the stock down 6% on Thursday alone. While top-line revenue grew by 5.7% over the last year, the underlying stock performance reflects a market reassessing near...
-
Stronger Bet Than Abbott Laboratories Stock: RMD Delivers More
RMD is Abbott Laboratories’s peer in Health Care Equipment industry that has: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation and perfo...
-
Pay Less, Gain More: RMD Tops Abbott Laboratories Stock
RMD is Abbott Laboratories’s peer in Health Care Equipment industry that has: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation and perfo...
-
Why RMD Could Outperform Abbott Laboratories Stock
RMD is Abbott Laboratories’s peer in Health Care Equipment industry that has: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation and perfo...
-
Better Value & Growth: STE, RMD Lead Abbott Laboratories Stock
STE, RMD are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Pay Less, Gain More: STE, RMD Top Abbott Laboratories Stock
STE, RMD are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Pay Less, Gain More: STE, RMD Top Abbott Laboratories Stock
STE, RMD are Abbott Laboratories’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation a...
-
Abbott Laboratories Stock Now 18% Cheaper, Time To Buy
Abbott Laboratories (ABT) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable prof...
-
Abbott Laboratories Stock: Join the Rally at a 19% Discount
Abbott Laboratories (ABT) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable prof...
-
Pay Less, Gain More: RMD Tops Abbott Laboratories Stock
RMD is Abbott Laboratories’s peer in Health Care Equipment industry that has: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation and perfo...
-
Buy or Sell Abbott Laboratories Stock?
Abbott Laboratories (ABT) stock has fallen 10% during the past day, and is currently trading at $108.61. We believe there are only a couple of things to fear in ABT stock given its overall Moderate operating performance and financial condition. ...
-
Is Abbott Laboratories Stock Built to Withstand More Downside?
Abbott Laboratories (ABT) stock is down 10.0% in a day. The recent slide reflects renewed concerns around a revenue miss and slowing growth in its diagnostics and nutrition segments, but sharp drops like this often raise a tougher question: is th...
-
How Did Abbott Fare In Q4 And What Lies Ahead?
Abbott Laboratories posted Q4 2025 sales of $11.46 billion, up 4.4% year-over-year but missing analyst estimates by about 3%. Adjusted EPS came in at $1.50, meeting expectations, while full-year adjusted EPS hit $5.15, reflecting 10% growth. Can ...
-
Pay Less, Gain More: RMD Tops Abbott Laboratories Stock
RMD is Abbott Laboratories’s peer in Health Care Equipment industry that has: 1) Lower valuation (P/OpInc) compared to Abbott Laboratories stock 2) But higher revenue and operating income growth This disconnect between valuation and perfo...
